Rhodopsins
are seven α-helical membrane proteins that are
of great importance in chemistry, biology, and modern biotechnology.
Any in silico study on rhodopsin properties and functioning requires
a high-quality three-dimensional structure. Due to particular difficulties
with obtaining membrane protein structures from the experiment, in
silico prediction of the three-dimensional rhodopsin structure based
only on its primary sequence is an especially important task. For
the last few years, significant progress was made in the field of
protein structure prediction, especially for methods based on comparative
modeling. However, the majority of this progress was made for soluble
proteins and further investigations are needed to achieve similar
progress for membrane proteins. In this paper, we evaluate the performance
of modern protein structure prediction methodologies (implemented
in the Medeller, I-TASSER, and Rosetta packages) for their ability
to predict rhodopsin structures. Three widely used methodologies were
considered: two general methodologies that are commonly applied to
soluble proteins and a methodology that uses constraints that are
specific for membrane proteins. The test pool consisted of 36 target-template
pairs with different sequence similarities that was constructed on
the basis of 24 experimental rhodopsin structures taken from the RCSB
database. As a result, we showed that all three considered methodologies
allow obtaining rhodopsin structures with the quality that is close
to the crystallographic one (root mean square deviation (RMSD) of
the predicted structure from the corresponding X-ray structure up
to 1.5 Å) if the target-template sequence identity is higher
than 40%. Moreover, all considered methodologies provided structures
of average quality (RMSD < 4.0 Å) if the target-template sequence
identity is higher than 20%. Such structures can be subsequently used
for further investigation of molecular mechanisms of protein functioning
and for the development of modern protein-based biotechnologies.